Table 3. Multivariate odds of past or current acetylcholinesterase inhibitor use among the 2,546 patients with Alzheimer disease*.
Characteristic | Odds ratio | 95% CI |
---|---|---|
African American | 0.6 | 0.4–0.9 |
Latino | 0.9 | 0.7–1.1 |
Asian | 0.7 | 0.5–1.0 |
Other | 0.5 | 0.3–0.9 |
White | 1.0 (ref) | |
Age per 5 y | 0.9 | 0.8–0.9 |
Education per 5 y | 1.1 | 1.0–1.3 |
Female | 0.9 | 0.7–1.1 |
Lives alone | 0.8 | 0.6–1.1 |
Lives in a household | 0.8 | 0.6–1.0 |
Lives in a health facility/group setting | 1.00 | 0.7–1.4 |
Lives with Spouse | 1.0 (ref) | |
Spouse caregiver | 1.4 | 1.0–1.8 |
Child/other caregiver | 1.0 (ref) | |
Medicare part A or B | 1.4 | 1.1–1.8 |
MediCal | 0.6 | 0.4–0.8 |
Other health insurance | 1.3 | 1.1–1.6 |
No health insurance | 0.5 | 0.3–1.0 |
Hypertension | 1.3 | 1.1–1.5 |
Diabetes | 1.0 | 0.8–1.4 |
MMSE score | ||
<12 | 1.4 | 1.1–1.8 |
12–19 | 1.2 | 1.0–1.5 |
>19 | 1.0 (ref) | |
BRDRS score | ||
>5.5 | 1.7 | 1.3–2.3 |
2.5–5.5 | 1.2 | 1.0–1.6 |
<2.5 | 1.0 (ref) |
Data on covariates missing for 27 patients.
MMSE = Mini-Mental State Examination; BRDRS = Blessed-Roth Dementia Rating Scale.